Abiomed Inc. | Balance Sheet

Fiscal year is April-March. All values USD Thousands.
2014
2015
2016
2017
2018
2019
Cash & Short Term Investments
76,579.00
131,958.00
212,053.00
229,948.00
362,249.00
492
Total Accounts Receivable
24,357.00
31,828.00
42,821.00
54,055.00
70,010.00
91
Inventories
13,948.00
16,774.00
26,740.00
34,931.00
50,204.00
81
Other Current Assets
3,082.00
39,579.00
6,778.00
8,024.00
11,808.00
14
Total Current Assets
117,966.00
220,139.00
288,392.00
326,958.00
494,271.00
677
Net Property, Plant & Equipment
6,889.00
9,127.00
23,184.00
87,777.00
117,167.00
145
Total Investments and Advances
41,761.00
13,996.00
5,400.00
54,343.00
50,102.00
102
Intangible Assets
37,990.00
46,245.00
48,399.00
45,527.00
52,513.00
51
Other Assets
801.00
3,654.00
22.00
1,086.00
1,576.00
2
Total Assets
205,407.00
338,367.00
423,931.00
550,414.00
786,375.00
1,054
ST Debt & Current Portion LT Debt
-
-
-
799.00
-
Accounts Payable
7,746.00
10,389.00
9,381.00
20,620.00
23,565.00
Income Tax Payable
1,445.00
1,506.00
2,527.00
3,180.00
4,562.00
Other Current Liabilities
21,220.00
27,424.00
34,633.00
45,018.00
56,555.00
Total Current Liabilities
30,411.00
39,319.00
46,541.00
69,617.00
84,682.00
Long-Term Debt
-
-
-
15,539.00
-
Provision for Risks & Charges
-
6,510.00
7,563.00
9,153.00
10,490.00
Deferred Taxes
6,415.00
44,411.00
57,702.00
33,940.00
69,843.00
Other Liabilities
228.00
183.00
220.00
3,251.00
776.00
Total Liabilities
37,054.00
46,807.00
55,156.00
98,343.00
96,851.00
Common Equity (Total)
168,353.00
291,560.00
368,775.00
452,071.00
689,524.00
Total Shareholders' Equity
168,353.00
291,560.00
368,775.00
452,071.00
689,524.00
Total Equity
168,353.00
291,560.00
368,775.00
452,071.00
689,524.00
Liabilities & Shareholders' Equity
205,407.00
338,367.00
423,931.00
550,414.00
786,375.00

About Abiomed

View Profile
Address
22 Cherry Hill Drive
Danvers Massachusetts 01923
United States
Employees -
Website http://www.abiomed.com
Updated 07/08/2019
ABIOMED, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It distributes its products under the Impella brand. The company was founded in 1981 and is headquartered in Danvers, MA.